Albert Chiou, MD, MBA, is a board-certified dermatologist and clinical associate professor of dermatology at the Stanford University School of Medicine in California.
Expert Insights Highlight Novel ITK Inhibition With Soquelitinib for AD
Albert Chiou, MD, MBA, discusses early clinical data on soquelitinib for atopic dermatitis, highlighting its targeted ITK inhibition, dose-dependent efficacy, favorable safety profile, and more.